Responsive image

Common name


benzene

IUPAC name


benzene

SMILES


c1ccccc1

Common name


benzene

IUPAC name


benzene

SMILES


c1ccccc1

INCHI


InChI=1S/C6H6/c1-2-4-6-5-3-1/h1-6H

FORMULA


C6H6

Responsive image

Common name


benzene

IUPAC name


benzene





Molecular weight


78.112

clogP


2.116

clogS


-1.364

Frequency


0.2824





HBond Acceptor


0

HBond Donor


0

Total Polar
Surface Area


0

Number of Rings


1

Rotatable Bond


0

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00094 Reserpine Responsive image Antihypertensive Agents; Adrenergic Uptake Inhibitors; Antipsychotic Agents; Adrenergic Antagonists; Cardiovascular System; Rauwolfia Alkaloids; Antiadrenergic Agents, Centrally Acting; BSEP/ABCB11 Inhibitors; Foe the treatment of hypertension.
FDBD00097 Trospium Responsive image Muscarinic Antagonists; Parasympatholytics; Genito Urinary System and Sex Hormones; Alimentary Tract and Metabolism; Drugs for Functional Gastrointestinal Disorders; Drugs for Urinary Frequency and Incontinence; Urological Agents; CYP2D6 Inducers; CYP2D6 Inducers (strong); For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency, detrusor instability and frequency of micturition.
FDBD00098 Adapalene Responsive image Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Anti-Acne Preparations; Dermatologicals; Retinoids for Topical Use in Acne; Anti-Acne Preparations for Topical Use; For the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back.
FDBD00099 Midodrine Responsive image Vasoconstrictor Agents; Sympathomimetics; Adrenergic alpha-1 Receptor Agonists; Cardiovascular System; Cardiac Therapy; Adrenergic and Dopaminergic Agents; Cardiac Stimulants Excl. Cardiac Glycosides; CYP2D6 Inducers; CYP2D6 Inducers (strong); For the treatment of symptomatic orthostatic hypotension (OH).
FDBD00100 Remikiren Responsive image Cardiovascular System; Agents Acting on the Renin-Angiotensin System; Renin-Inhibitors; For the treatment of hypertension and heart failure.
FDBD00104 Eletriptan Responsive image Analgesics; Serotonin Antagonists; Serotonin Receptor Agonists; Anti-migraine Agents; Nervous System; Selective Serotonin (5Ht1) Agonists; Antimigraine Preparations; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2A6 Inhibitors; CYP2A6 Inhibitors (strong); CYP2A6 Inhibitors (moderate); CYP2A6 Inducers; CYP2A6 Inducers (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; For the acute treatment of migraine with or without aura in adults.
FDBD00105 Bethanidine Responsive image Antihypertensive Agents; Adrenergic Agents; Sympatholytics; Cardiovascular System; Guanidine Derivatives; Antiadrenergic Agents, Peripherally Acting; Alpha2 Agonists; For the treatment of hypertension.
FDBD00107 Oxyphenonium Responsive image Muscarinic Antagonists; Parasympatholytics; Mydriatics; Alimentary Tract and Metabolism; Drugs for Functional Gastrointestinal Disorders; Synthetic Anticholinergics, Quaternary Ammonium Compounds; For the treatment of visceral spasms.
FDBD00108 Nelfinavir Responsive image Protease Inhibitors; HIV Protease Inhibitors; Antiinfectives for Systemic Use; Direct Acting Antivirals; Antivirals for Systemic Use; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; Used in combination with other antiviral drugs in the treatment of HIV in both adults and children.
FDBD00110 Glimepiride Responsive image Hypoglycemic Agents; Immunosuppressive Agents; Anti-Arrhythmia Agents; Drugs Used in Diabetes; Alimentary Tract and Metabolism; Blood Glucose Lowering Drugs, Excl. Insulins; Sulfonylureas; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; For concomitant use with insulin for the treatment of noninsulin-dependent (type 2) diabetes mellitus.
822 , 83
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
4i7j_ligand_frag_0.mol2 4i7j 1 -6.96 c1ccccc1 6
4i7j_ligand.mol2 4i7j 1 -6.96 c1ccccc1 7
4w52_ligand_frag_0.mol2 4w52 1 -6.95 c1ccccc1 6
4w52_ligand.mol2 4w52 1 -6.95 c1ccccc1 7
1fl3_ligand_frag_0.mol2 1fl3 1 -6.92 c1ccccc1 6
220l_ligand_frag_0.mol2 220l 1 -6.92 c1ccccc1 6
220l_ligand.mol2 220l 1 -6.92 c1ccccc1 7
223l_ligand_frag_0.mol2 223l 1 -6.92 c1ccccc1 6
223l_ligand.mol2 223l 1 -6.92 c1ccccc1 7
4w55_ligand_frag_2.mol2 4w55 1 -6.92 c1ccccc1 6
5255 , 526